Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vandenberghe

Showing results (101-110 of 185) with videos related to

Pageof 19
Sort By:
Cancer Genetics and Cytogenetics|September 25, 2007
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosisJoris Andrieux, Catherine Roche-Lestienne, Sandrine Geffroy, et al.
Leukemia|May 10, 2018
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemiaJolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
Haematologica|May 3, 2015
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutationsCarla Al Assaf, Florence Van Obbergh, Johan Billiet, et al.
Blood|February 18, 2011
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, et al.
Molecular Cancer|December 17, 2015
t(15;21) translocations leading to the concurrent downregulation of RUNX1 and its transcription factor partner genes SIN3A and TCF12 in myeloid disordersAlberto L'Abbate, Doron Tolomeo, Francesca De Astis, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Cancer Genetics and Cytogenetics|September 15, 2005
Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9)Constantina Sambani, Roberta La Starza, Valentina Pierini, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Genes, Chromosomes & Cancer|July 23, 2013
BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphomaLeila Rouhigharabaei, Julio Finalet Ferreiro, Natalie Put, et al.
Pageof 19

Showing results (101-110 of 185) with videos related to

Sort By:
Pageof 19
Cancer Genetics and Cytogenetics|September 25, 2007
Bone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosisJoris Andrieux, Catherine Roche-Lestienne, Sandrine Geffroy, et al.
Leukemia|May 10, 2018
Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemiaJolien De Bie, Sofie Demeyer, Llucia Alberti-Servera, et al.
Annals of Hematology|July 24, 2015
Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion geneElisa Rumi, Jelena D Milosevic, Dominik Selleslag, et al.
Haematologica|May 3, 2015
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutationsCarla Al Assaf, Florence Van Obbergh, Johan Billiet, et al.
Blood|February 18, 2011
JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphomaKatrien Van Roosbroeck, Luk Cox, Thomas Tousseyn, et al.
Molecular Cancer|December 17, 2015
t(15;21) translocations leading to the concurrent downregulation of RUNX1 and its transcription factor partner genes SIN3A and TCF12 in myeloid disordersAlberto L'Abbate, Doron Tolomeo, Francesca De Astis, et al.
Cancer Immunology, Immunotherapy : CII|April 27, 2020
In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapyLukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, et al.
Cancer Genetics and Cytogenetics|September 15, 2005
Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9)Constantina Sambani, Roberta La Starza, Valentina Pierini, et al.
Blood|May 10, 2011
PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemiaMaria Kleppe, Jean Soulier, Vahid Asnafi, et al.
Genes, Chromosomes & Cancer|July 23, 2013
BMI1, the polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphomaLeila Rouhigharabaei, Julio Finalet Ferreiro, Natalie Put, et al.
Pageof 19